Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tabalumab in Moderate to Severe Rheumatoid Arthritis (FLEX M)
NCT01198002Phase 3Terminated
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2010
- Primary completion
- Dec 2012
- Countries
- 23
01
Overview
A Phase 3 trial of tabalumab in rheumatoid arthritis (RA), sponsored by Eli Lilly and Company. Started Dec 2010; status: terminated.
02
Drugs
tabalumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01198002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01198002.